most citedAssessing the Impact of COVID-19 on the Objective and Analysis of Oncology Clinical Trials -- Application of the Estimand Framework

36 citations · 36 across the 2 of their papers we have counts for

collaborators
Showing stat.APShow all

1 paper · 1 filter

stat.AP2022

Time-to-event estimands and loss to follow-up in oncology in light of the estimands framework

Jonathan Siegel, Hans-Jochen Weber, Stefan Englert +1

Time-to-event estimands are central to many oncology clinical trials. The estimand framework (addendum to the ICH E9 guideline) calls for precisely defining the treatment effect of…